Oral administration of heat-killed Lactobacillus plantarum L-137 enhances protection against influenza virus infection by stimulation of type I interferon production in mice

International Immunopharmacology

Volumn 9, Issue 9, 2009, Pages 1122-1125

  Maeda, Naoyoshi ^a   Nakamura, Risa ^a   Hirose, Yoshitaka ^b   Murosaki, Shinji ^b   Yamamoto, Yoshihiro ^b   Kase, Tetsuo ^c   Yoshikai, Yasunobu ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b HOUSE WELLNESS FOODS CORPORATION   (Japan)

^c OSAKA PREFECTURAL INSTITUTE OF PUBLIC HEALTH   (Japan)

Author keywords

Influenza virus; Lactobacillus plantarum L 137; Type I interferon

Indexed keywords

ANTIINFECTIVE AGENT; BETA INTERFERON; L 137; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; C57BL 6 MOUSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; HEAT; INFLUENZA; INFLUENZA VIRUS A H1N1; LACTOBACILLUS PLANTARUM; LUNG; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROPHYLAXIS; PROTECTION; PROTEIN ANALYSIS; SERUM; SURVIVAL TIME; VIRUS STRAIN;

ADMINISTRATION, ORAL; ANIMALS; FEMALE; INFLUENZA VACCINES; INTERFERON TYPE I; LACTOBACILLUS PLANTARUM; LUNG; MICE; MICE, INBRED C57BL; ORTHOMYXOVIRIDAE; ORTHOMYXOVIRIDAE INFECTIONS; PROBIOTICS; VACCINES, INACTIVATED; VIRAL LOAD;

EID: 67649394141     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.intimp.2009.04.015     Document Type: Article

References (34)

1. Gillim-Ross L., and Subbarao K. Emerging respiratory viruses: challenges and vaccine strategies. Clin Microbiol Rev 19 (2006) 614
2. Studahl M. Influenza virus and CNS manifestations. J Clin Virol 28 (2003) 225-232
3. Doherty P.C., Turner S.J., Webby R.G., and Thomas P.G. Influenza and the challenge for immunology. Nat Immunol 7 (2006) 449-455
4. La Gruta N.L., Kedzierska K., Stambas J., and Doherty P.C. A question of self-preservation: immunopathology in influenza virus infection. Immunol Cell Biol 85 (2007) 85-92
5. Thomas P.G., Keating R., Hulse-Post D.J., and Doherty P.C. Cell-mediated protection in influenza infection. Emerg Infect Dis 12 (2006) 48-54
6. Erickson K.L., and Hubbard N.E. Probiotic immunomodulation in health and disease. J Nutr 130 (2000) 403S-409S
7. Nomoto K. Prevention of infections by probiotics. J Biosci Bioeng 100 (2005) 583-592
8. Yasui H., Shida K., Matsuzaki T., and Yokokura T. Immunomodulatory function of lactic acid bacteria. Antonie Van Leeuwenhoek 76 (1999) 383-389
9. Murosaki S., Yamamoto Y., Ito K., Inokuchi T., Kusaka H., Ikeda H., et al. Heat-killed Lactobacillus plantarum L-137 suppresses naturally fed antigen-specific IgE production by stimulation of IL-12 production in mice. J Allergy Clin Immunol 102 (1998) 57-64
10. Murosaki S., Muroyama K., Yamamoto Y., Kusaka H., Liu T., and Yoshikai Y. Immunopotentiating activity of nigerooligosaccharides for the T helper 1-like immune response in mice. Biosci Biotechnol Biochem 63 (1999) 373-378
11. Murosaki S., Muroyama K., Yamamoto Y., and Yoshikai Y. Antitumor effect of heat-killed Lactobacillus plantarum L-137 through restoration of impaired interleukin-12 production in tumor-bearing mice. Cancer Immunol Immunother 49 (2000) 157-164
12. Hirose Y., Murosaki S., Yamamoto Y., Yoshikai Y., and Tsuru T. Daily intake of heat-killed Lactobacillus plantarum L-137 augments acquired immunity in healthy adults. J Nutr 136 (2006) 3069-3073
13. Mohamadzadeh M., Olson S., Kalina W.V., Ruthel G., Demmin G.L., Warfield K.L., et al. Lactobacilli activate human dendritic cells that skew T cells toward T helper 1 polarization. Proc Natl Acad Sci U S A 102 (2005) 2880-2885
14. Rasmussen Jr. A.F., Stokes J.C., and Smadel J.E. The army experience with influenza, 1946-1947 II Laboratory aspects. Am J Hygiene 47 (1948) 142-149
15. Brown E.G. Increased virulence of a mouse-adapted variant of influenza A/FM/1/47 virus is controlled by mutations in genome segments 4, 5, 7, and 8. J Virol 64 (1990) 4523-4533
16. Brown E.G., Dimock C.F., and Hannah K. Interference is controlled by segment 2 and possibly by segment 8 of the nondefective interfering influenza virus variant A/FM/1/47-MA. J Virol 66 (1992) 6314-6321
17. Smeenk C.A., and Brown E.G. The influenza virus variant A/FM/1/47-MA possesses single amino acid replacements in the hemagglutinin, controlling virulence, and in the matrix protein, controlling virulence as well as growth. J Virol 68 (1994) 530-534
18. Brown E.G., and Bailly J.E. Genetic analysis of mouse-adapted influenza A virus identifies roles for the NA, PB1, and PB2 genes in virulence. Virus Res 61 (1999) 63-76
19. Brown E.G., Liu H., Kit L.C., Baird S., and Nesrallah M. Pattern of mutation in the genome of influenza A virus on adaptation to increased virulence in the mouse lung: identification of functional themes. Proc Natl Acad Sci U S A 98 (2001) 6883-6888
20. Okuno Y., Matsumoto K., Isegawa Y., and Ueda S. Protection against the mouse-adapted A/FM/1/47 strain of influenza A virus in mice by a monoclonal antibody with cross-neutralizing activity among H1 and H2 strains. J Virol 68 (1994) 517-520
21. Kawai T., and Akira S. Toll-like receptor and RIG-I-like receptor signaling. Ann N Y Acad Sci 1143 (2008) 1-20
22. Hale B.G., Randall R.E., Ortín J., and Jackson D. The multifunctional NS1 protein of influenza A viruses. J Gen Virol 89 (2008) 2359-2376
23. Loo Y.M., Fornek J., Crochet N., Bajwa G., Perwitasari O., Martínez-Sobrido L., et al. Distinct RIG-I and MDA5 signaling by RNA viruses in innate immunity. J Virol 82 (2008) 335-345
24. Mibayashi M., Martínez-Sobrido L., Loo Y.M., Cárdenas W.B., Gale Jr. M., and García-Sastre A. Inhibition of retinoic acid-inducible gene I-mediated induction of beta interferon by the NS1 protein of influenza A virus. J Virol 81 (2007) 514-524
25. Jackson D., Hossain M.J., Hickman D., Perez D.R., and Lamb R.A. A new influenza virus virulence determinant: the NS1 protein four C-terminal residues modulate pathogenicity. Proc Natl Acad Sci U S A 105 (2008) 4381-4386
26. Krystal M., Buonagurio D., Young J.F., and Palese P. Sequential mutations in the NS genes of influenza virus field strains. J Virol 45 (1983) 547-554
27. Matikainen S., Sirén J., Tissari J., Veckman V., Pirhonen J., Severa M., et al. Tumor necrosis factor alpha enhances influenza A virus-induced expression of antiviral cytokines by activating RIG-I gene expression. J Virol 80 (2006) 3515-3522
28. Cleveland M.G., Gorham J.D., Murphy T.L., Tuomanen E., and Murphy K.M. Lipoteichoic acid preparations of gram-positive bacteria induce interleukin-12 through a CD14-dependent pathway. Infect Immun 64 (1996) 1906-1912
29. Matsuguchi T., Takagi A., Matsuzaki T., Nagaoka M., Ishikawa K., Yokokura T., et al. Lipoteichoic acids from Lactobacillus strains elicit strong tumor necrosis factor alpha-inducing activities in macrophages through Toll-like receptor 2. Clin Diagn Lab Immunol 10 (2003) 259-266
30. Yasui H., Kiyoshima J., and Hori T. Reduction of influenza virus titer and protection against influenza virus infection in infant mice fed Lactobacillus casei Shirota. Clin Diagn Lab Immunol 11 (2004) 675-679
31. Yasui H., Nagaoka N., and Hayakawa K. Augmentation of anti-influenza virus hemagglutinin antibody production by Peyer's patch cells with Bifidobacterium breve YIT4064. Clin Diagn Lab Immunol 1 (1994) 244-246
32. Yasui H., Kiyoshima J., Hori T., and Shida K. Protection against influenza virus infection of mice fed Bifidobacterium breve YIT4064. Clin Diagn Lab Immunol 6 (1999) 186-192
33. Olivares M., Díaz-Ropero M.P., Sierra S., Lara-Villoslada F., Fonollá J., Navas M., et al. Oral intake of Lactobacillus fermentum CECT5716 enhances the effects of influenza vaccination. Nutrition 23 (2007) 254-260
34. Maines T.R., Szretter K.J., Perrone L., Belser J.A., Bright R.A., Zeng H., et al. Pathogenesis of emerging avian influenza viruses in mammals and the host innate immune response. Immunol Rev 225 (2008) 68-84